November 7, 2024 10:53 AM EST
News Briefing

Geron’s roy­al­ty deal; Minghui’s new VEGF bis­pe­cif­ic da­ta

ENDPOINTS

Plus, news about ADC Ther­a­peu­tics, Celldex and Virac­ta Ther­a­peu­tics:

Geron inks up to $375M roy­al­ty and debt deal: The com­pa­ny now

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Take­da an­nounces hand­ful of pipeline cuts in ef­fort to ‘piv­ot re­sources’

GSK awaits Nu­cala de­ci­sion af­ter FDA tar­get date pass­es

AI-fo­cused biotech in­sitro cuts 22% of staff, cit­ing 'tu­mul­tuous mar­ket'

As­traZeneca los­es ap­peals court fight over IRA drug price ne­go­ti­a­tions

'Find a way, or make one': How two sci­en­tists hope to re­vi­tal­ize CRISPR's rare dis­ease cri­sis

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times